New asthma drug faces off against tezspire in major trial
NCT ID NCT07302516
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study tests if a new drug called QL2302 works as well as the approved drug Tezspire for adults with severe asthma that is not controlled by current treatments. About 636 people will get injections every 4 weeks for 48 weeks, then be monitored for 12 more weeks. The main goal is to see how often asthma attacks happen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.